Return to content in this issue
Changes of Thymus and Activation-Regulated Chemokine in Type 2 Inflammatory Disease Patients with Dupilumab Treatment
Zhou B, Liang S, Shang S, Xiang L, Li L
Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
J Investig Allergol Clin Immunol 2023; Vol. 33(1)
doi: 10.18176/jiaci.0874
Key words: Thymus and activation-regulated chemokine, Type 2 Inflammatory disease, Atopic dermatitis, Dupilumab
| Title | Type | Size | |
|---|---|---|---|
 |
doi10.18176_jiaci.0874_supplemental-materials-tables.pdf | 196.63 Kb | |
|
doi10.18176_jiaci.0874_supplemental-materials-figures.pdf | 3.14 Mb |
